Presentation is loading. Please wait.

Presentation is loading. Please wait.

Drug Treatment Monitoring Unit

Similar presentations


Presentation on theme: "Drug Treatment Monitoring Unit"— Presentation transcript:

1 Drug Treatment Monitoring Unit
NDTMS Core Dataset G Training for Treatment Providers and Commissioners Drug Treatment Monitoring Unit March 2010

2 Ground Rules Please respect those around you by not holding individual conversations whilst the sessions are in progress Please put mobiles on silent/vibrate Please take any calls outside of the meeting

3 Aims Clarify the changes in Core Data Set ‘G’
Clarify consent and confidentiality Review Data Quality and TOP compliance Provide information around current reporting and monitoring Clarify numbers in effective treatment, successful completions and waiting times calculations April 6, 2017

4 Essential Elements of Treatment Provision
The needs of all drug misusers should be assessed across the four domains of drug and alcohol misuse health social functioning and criminal involvement. All drug misusers entering structured drug treatment should have a care or treatment plan which is regularly reviewed. A named individual should manage and deliver aspects of the patient’s care or treatment plan. (Source: Drug Misuse and Dependence: UK guidelines on clinical management‚ 2007) NDTMS collects information all four domains April 6, 2017

5 Why is information needed for NDTMS?
The drug and alcohol treatment information that you provide to the NDTMS is used for several purposes. Primarily used for: Assess the number of individuals attending drug and alcohol services in order to monitor the progress of the national drug and alcohol strategies; Evaluate the efficiency and effectiveness of drug and alcohol treatment provision‚ including treatment outcomes for clients. Monitor the use of resources. This helps ensure equitable funding of drug and alcohol services nationally. Provide a local and regional picture of drug and alcohol clients and their needs‚ which will assist service commissioners such as DAATs‚ PCTs and local authorities in planning and developing better drug and alcohol treatment services that are more appropriate to their geographical area. Produce statistics and to support research on drug and alcohol use‚ treatment or general public. April 6, 2017

6 DAAT Profile: 2008-09 http://www.dtmu.org.uk/DAT Profiles 2008-09.html
The DTMU DAAT Profiles for Adults and YP for 2008/09 were released in February Electronic copies of these reports can be found on April 6, 2017

7 Changes with Core Data Set G
One new data item Modalities updated in line with Orange Book clinical guidance Reference data items updated in line with NHS data dictionary YP outcomes updated April 6, 2017

8 New data item: Local agency details
Field to be reviewed by regional team Collected at Modality start Intended to be used to report prescribing on behalf of another agency Possible values: GP, Pharmacist, NDTMS agency code, GP practice code April 6, 2017

9 CDS ‘G’ Treatment Interventions Updated options
April 6, 2017

10 Updated treatment interventions
Modalities updated in line with Orange Book clinical guidance “The SCAN consensus document on inpatient treatment (SCAN, 2006) defined the core work of an inpatient unit as comprising assessment, stabilisation and detoxification (or assisted withdrawal). Although these may be combined during a patient’s stay, the patient’s plan of care should usually identify one task as the principal purpose of administration” Proposals to modify the codes used to record the types of drug treatment being provided on the National Drug Treatment Monitoring System – July 2009 April 6, 2017

11 Tier 2 Adult Drug Modalities
Outreach Advice and Information Needle Exchange Aftercare Clients receiving these Tier 2 interventions will NOT count for performance targets 1. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.

12 Tier 3 Adult Drug Modalities
Specialist Prescribing GP Prescribing Behavioural Couples Therapy Family Therapy Contingency Management (drug specific) Psychosocial Intervention to address common mental disorders Other Formal Psychosocial Therapy Structured Day Programme Other Structured Intervention Clients receiving these Tier 3 interventions will count for performance targets 1. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.

13 Psychosocial interventions
Behavioural couples therapy Family therapy Contingency management (drug specific) Psychosocial interventions to address common mental disorders Other formal psychosocial therapy (e.g. community reinforcement approach or social behaviour network therapy) Structured psychosocial interventions have been expanded: 81 – Behavioural couples therapy 82 – Family therapy 83 – Contingency management (drug specific) 84 – Psychosocial interventions to address common mental disorders 85 – Other formal psychosocial therapy April 6, 2017

14 Behavioural couples therapy
Behavioural couples therapy is a specific psychosocial intervention that should only be available for use with clients who have an established relationship and a drug-free partner willing to engage in treatment. The focus is on the client’s drug use and should consist of at least twelve weekly sessions. Structured psychosocial interventions have been expanded: 81 – Behavioural couples therapy 82 – Family therapy 83 – Contingency management (drug specific) 84 – Psychosocial interventions to address common mental disorders 85 – Other formal psychosocial therapy April 6, 2017

15 Family therapy Family therapy is a structured psychosocial intervention that is delivered by a competent clinician. The focus is on discussion with families relating to the sources of stress associated with drug misuse and aims to support and promote the family in developing more effective coping behaviours. Family therapy should only be recorded under this code when the client is actively involved in the intervention. This does not reflect family work that is done where the service user is not engaged in the intervention. Structured psychosocial interventions have been expanded: 81 – Behavioural couples therapy 82 – Family therapy 83 – Contingency management (drug specific) 84 – Psychosocial interventions to address common mental disorders 85 – Other formal psychosocial therapy April 6, 2017

16 Contingency management (drug specific)
Structured behavioural programmes using incentives to reinforce changes in behaviour. Behaviour changes incentivised for people receiving methadone maintenance treatment include reduced illicit drug use and/or increased engagement with services. Behaviour changes incentivised for people who primarily misuse stimulants include reduced illicit drug use, abstinence and/or increased engagement with services. Structured psychosocial interventions have been expanded: 81 – Behavioural couples therapy 82 – Family therapy 83 – Contingency management (drug specific) 84 – Psychosocial interventions to address common mental disorders 85 – Other formal psychosocial therapy April 6, 2017

17 Psychosocial interventions to address common mental disorders
Many drug users also have considerable co-morbid problems, particularly common mental health problems such as anxiety and depression. There is evidence that a range of evidence-based psychosocial interventions can be beneficial for a wide range of mental disorders. Such disorders may include: depression (NICE, 2007b); anxiety (NICE, 2007c); post traumatic stress disorder (NICE, 2005a); eating disorders (NICE, 2004); obsessive compulsive disorder (NICE, 2005b); antenatal and postnatal mental health (NICE, 2007d) Psychosocial interventions to address these disorders range from, for example, guided self help and brief interventions for mild forms of problems to cognitive behavioural therapy and social support for more moderate forms. All psychosocial intervention to address common mental disorders should be recorded using this code regardless of their intensity. Structured psychosocial interventions have been expanded: 81 – Behavioural couples therapy 82 – Family therapy 83 – Contingency management (drug specific) 84 – Psychosocial interventions to address common mental disorders 85 – Other formal psychosocial therapy April 6, 2017

18 Other formal psychosocial therapy
(e.g. community reinforcement approach or social behaviour network therapy) This includes other psychosocial therapies that are used in drug treatment and beneficial for some clients as they are practical and broad-based techniques. Psychosocial therapies recorded under this category will include the Community Reinforcement Approach and Social Behaviour Network Therapy. Structured psychosocial interventions have been expanded: 81 – Behavioural couples therapy 82 – Family therapy 83 – Contingency management (drug specific) 84 – Psychosocial interventions to address common mental disorders 85 – Other formal psychosocial therapy April 6, 2017

19 Tier 4 Adult Drug Modalities
Inpatient Treatment Assessment Only Inpatient Treatment Stabilisation Inpatient Treatment Detoxification (assisted withdrawal) Residential Rehabilitation Clients receiving these Tier 4 interventions will count for performance targets 1. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.

20 Inpatient treatment Inpatient treatment Assessment Only
Inpatient treatment Stabilisation Inpatient treatment Detoxification 87 - Inpatient treatment Assessment Only 88 – Inpatient treatment Stabilisation 89 – Inpatient treatment Detoxification April 6, 2017

21 Inpatient treatment Assessment Only
Individuals with drug and alcohol dependence present with a wide range of psychiatric, physical and social problems. Substance misuse services provide a comprehensive assessment of these needs and formulate a treatment care plan to tackle them. A hospital setting permits a higher level of medical observation, supervision and safety for service users needing more intensive forms of care. Specific tasks of the IPU may include: • Assessment of substance use • Assessment of mental health • Assessment of physical health • Assessment of social problems These should be undertaken as described in the Inpatient Treatment of Drug and Alcohol Misusers in the National Health Service – Scan consensus project (2006). This document is available at using the following link. April 6, 2017

22 Inpatient treatment Stabilisation
There is considerable evidence that the number of service users with more complex problems (coexisting physical and mental illness, dependence on more than one substance) is increasing. Such cases can be managed in a community setting, but the IPU setting permits a high level of medical observation, supervision and safety for service users needing more intensive forms of care. The IPU should have care pathways, clinical protocols, and sufficient human and physical resources to offer the following range of stabilisation procedures: 1. Dose titration 2. Dose titration on injectable opioid medication 3. Stabilisation on maintenance therapy 4. Combination assisted withdrawal/stabilisation April 6, 2017

23 Inpatient treatment Detoxification
Assisted withdrawal should only be encouraged as the first step in a longer treatment process, and needs to be integrated with relapse prevention or rehabilitation treatment programmes which can be provided in the NHS or independent/non-statutory sector. Withdrawal in an IPU setting offers better opportunities for clinicians to ensure compliance with medication and to manage complications. IPU admission also offers a major opportunity to recruit service users into longer-term treatment to reduce the risk of relapse back into regular drug or alcohol use. The IPU should have care pathways, clinical protocols, and sufficient human and physical resources to offer assisted withdrawal for a wide range of single and poly- drug and alcohol misuse problems. April 6, 2017

24 Adult Alcohol Modalities
Tier 3 ALC - Community Prescribing ALC - Structured Psychosocial Intervention ALC - Structured Day Programme ALC - Other Structured Treatment Tier 4 ALC - Inpatient Treatment ALC - Residential Rehabilitation Tier 2 ALC – Brief Interventions Will NOT count towards numbers in Treatment. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.

25 Young People Modalities
Tier 3 YP Psychosocial Intervention YP Harm Reduction Services YP Family Work YP Specialist Pharmacological Interventions Tier 4 YP Access to residential treatment for substance misuse Tier 2 YP Non-structured intervention Young People receiving these Tier 3/4 interventions will count towards performance targets Very clear that Psychosocial Interventions can include both one-to-one and group work – it is the care planned element that is key to whether or not it is considered to be T2/3 1. Will the tier 2 YP modalities still be available from 1st April 2007 (should these be removed from the slide?)

26 Question: Are you all reporting treatment modalities against individual clients episode of treatment? April 6, 2017

27 CDS ‘G’ Reference Data Changes to reference values in line with NHS Data Dictionary
27

28 Employment status Regular Employment Pupil/Student Long term sick or disabled Homemaker Retired from work Unemployed and seeking work Not receiving benefits Unpaid voluntary work Retired from paid work Not stated Other Not known ‘Long term sick or disabled’, ‘Homemaker’ and ‘Retired from work’ have all been included following expansion of previous ‘Economically inactive’ option. ‘Unemployed and seeking work’, ‘Not receiving benefits’, ‘Unpaid voluntary work’, ‘Retired from paid work’ and ‘Not stated’ have been included following expansion of previous ‘Unemployed’ option. April 6, 2017

29 Sexuality Gay: renamed to Homosexual
Not Disclosed: renamed to Not Recorded April 6, 2017

30 Consent Yes the person consented No the person has not consented
April 6, 2017

31 Previously Hep B Infected
Yes has had a previous Hepatitis B infection diagnosed; No has never had a previous Hepatitis B infection diagnosed; Not Known April 6, 2017

32 Hepatitis C Positive Yes is Hepatitis C Positive
No is not Hepatitis C Positive Not Known April 6, 2017

33 Injecting Status Previously Injected (but not currently)
Currently Injecting Never Injected Client Declined to Answer April 6, 2017

34 Referral Sources (Drug & Alcohol)
Arrest Referral / DIP is now: Arrest Referral DIP Custody Service has been removed April 6, 2017

35 Referral Sources (Alcohol Only)
Employer ATR (Alcohol Treatment Requirement) Peer April 6, 2017

36 Drug Codes Methylone Mephedrone No Second Drug No Third Drug
April 6, 2017

37 CDS ‘G’ Young People Changes to YP Outcomes
April 6, 2017

38 Changes to YP outcomes There are some changes to the YP outcomes.
These apply to all young people seen at a Young People’s treatment provider and should only be completed by these agencies. YP outcomes have been collected since April 2009. YP NDTMS Event: 31st March‚ YMCA Guildford April 6, 2017

39 Information Management
April 6, 2017

40 Information Management
Clinicians need to: Keep patient records; Ensure appropriate information sharing‚ confidentiality and data protection; Collect and analyse data; and Make effective use of information and data; (Drug Misuse and Dependence: UK guidelines on clinical management‚ 2007) If a client refuses consent – NDTMS and TOP should still be completed within your own system, consent flagged as no, and we will receive only minimal non-identifiable data. If the client is not aware that the DAAT would have sight of the attributable data, their row level data cannot be shared with the DAATs.

41 Information Sharing “Information sharing can be of great value to the direct care of individual patients and may also contribute indirectly to the delivery and effectiveness of the drug treatment system. Information sharing protocols should be consistent with guidance from local Caldicott Guardian and any national guidance‚ and acknowledge that patient consent to disclosure is key in most situations where identifiable information is shared.” (Drug Misuse and Dependence: UK guidelines on clinical management‚ 2007) If a client refuses consent – NDTMS and TOP should still be completed within your own system, consent flagged as no, and we will receive only minimal non-identifiable data. If the client is not aware that the DAAT would have sight of the attributable data, their row level data cannot be shared with the DAATs.

42 Data Sharing Protocols
Having data sharing protocols in place‚ that outline how and why data is shared within and between organisations‚ is good practice. Scenarios: DAT Wide Systems: this will necessitate information sharing across treatment services and/or Drug and Alcohol Action Teams; Multi-site service provider software (e.g. Addaction use one system nationally): Multiple service providers delivering simultaneous treatment to a client‚ irrespective of the software used. This is relevant to TOP data where a service provider should‚ subject to permissions and data sharing protocols‚ send copies of the TOP information to other agencies. Part of the assessment process should be establishing with a client how information relating to them may be shared and for what purpose. This may be done as part of the care planning process and should have started at the time of assessment.

43 Consent Clients should give written consent to share information about their care plan. This consent should specifically state which agencies the client consents to have information received about them and which they do not. A form recording the client’s consent should be kept in the notes. Consent should be reviewed at the time of reviewing the care plan. If a client refuses consent – NDTMS and TOP should still be completed within your own system, consent flagged as no, and we will receive only minimal non-identifiable data. If the client is not aware that the DAAT would have sight of the attributable data, their row level data cannot be shared with the DAATs.

44 NTA Confidentiality Toolkit
Confidentiality policy should be clearly explained to client (verbally and written form), before assessment for treatment. Should cover: What information will be collected by the agency When and what information will be shared with other services and organisations Who information will go to and why (NDTMS) When the confidentiality may be breached (NTA Confidentiality Toolkit, 2009 NTA)

45 Discharge Data

46 Discharge Data Discharge Date Discharge Reason
If a Discharge Date is entered, then a Discharge Reason must be given and vice versa. Discharge information must be reported accurately and in a timely fashion as it is used to calculate In treatment Rates. Modality End Date (s) must be populated for discharged clients. If agencies want other discharge reasons added, we can put them forward to the NTA on their behalf. Can’t guarantee that it will be added, but we can try.

47 Drug Discharge Reasons
Successful Completions Treatment completed - drug free Treatment completed - occasional user (not opiates or crack)

48 Drug Discharge Reasons
Transfers Transferred – not in custody Transferred – in custody

49 Drug Discharge Reasons
Incomplete Incomplete – Dropped Out Incomplete – Treatment withdrawn by provider Incomplete – Retained in Custody Incomplete – Treatment Commencement Declined by Client Incomplete – Client Died

50 Planned Discharge Project
The DTMU are currently providing support to a national exercise around Planned and Unplanned Discharges being undertaken by the Regional NTA Teams.  The number of unplanned discharges is rising, a trend which the NTA is keen to address immediately.  In order to enable the agencies to investigate individual unplanned discharges, the DTMU have made available a spreadsheet which contains the attributable level data for unplanned discharges only for your service, thus the total number of discharges will be less than the summary sheet, which includes planned discharge reasons.  "The DTMU are currently providing support to a national exercise around Planned and Unplanned Discharges being undertaken by the Regional NTA Teams.  The number of unplanned discharges is rising, a trend which the NTA is keen to address immediately.  As such, they have provided information at a Partnership and Agency level about where clients are exiting the treatment system and what the corresponding discharge reasons are.  In order to enable the agencies to investigate individual unplanned discharges, the DTMU have made available a spreadsheet which contains the attributable level data for unplanned discharges only for your service, thus the total number of discharges will be less than the summary sheet, which includes planned discharge reasons.  This is available on the SE Region Dropbox, which I have set you up with access. We have notified the DAAT that we have shared this information with you. This data is to provide you with information around the clients who have left the treatment system in an unplanned way and this exit took place at your agency.  In order to try and improve client engagement with the treatment system and consequently the numbers of planned discharges from the treatment system, the following considerations should be made: - Referred on (where CDS-E has been reported in this financial year) or Transferred - not in custody This indicates that a client has been referred to another agency, and has not engaged in treatment.  In order to minimise drop-out at this point, it's important to consider your own agency processes around supporting that client until they have engaged in treatment at the new service.  What steps are taken to ensure that they arrive?  Is adequate information shared with the next agency to ensure that the client information is recorded consistently between the two agencies (initials/DOB)?  What happens if they don't turn up to the appointment?  How is this followed up?  What steps are taken to reengage that client with your own agency?  Are you using this to refer to Tier 2?  If so, why?  Tier 2 do not report to NDTMS, so the client will not appear at another agency and so be deemed as lost to the system.  Where this is aftercare, should a treatment completed reason have been more appropriately used at your agency to discharge the client?  Or, were they being referred back to Tier 2 to try and keep them engaged in the system? Answers to these questions should help you to understand where you can effectively focus your efforts to minimise drop-out from the structured treatment pathway. - Treatment Incomplete - Dropped out/Left What steps were taken to reengage the client?  Were they followed up?  Could anything more have been done?  Could they have been referred to another structured treatment agency for more appropriate interventions?  At what stage in their treatment journey were they - did they simply miss the final wrap-up meeting? Focusing efforts on these two areas should enable you to understand the reasons behind the levels of unplanned discharges in your agency and inform decisions around implementing improvements in processes that can support re-engaging or maintaining client engagement in the treatment system. If you have any queries, please contact us or the NTA Regional Deputy Manager for your partnership area."

51 Alcohol Discharge Reasons
Successful Completions Treatment completed - alcohol free Treatment completed - occasional user

52 Alcohol Discharge Reasons
Transfers Transferred – not in custody Transferred – in custody

53 Alcohol Discharge Reasons
Incomplete Incomplete – Dropped Out Incomplete – Treatment withdrawn by provider Incomplete – Retained in Custody Incomplete – Treatment Commencement Declined by Client Incomplete – Client Died

54 Treatment Outcomes Profile
Refresher April 6, 2017

55 What is the TOP? Treatment Outcomes Profile
• An instrument to measure treatment outcomes • A simple, short set of questions • To plot clients’ progress through structured treatment - a measure of how well clients do in treatment • Reported to NDTMS 55

56 All clinicians using the TOP should know the following 5 key messages
TOP: Key facts Clinical usefulness Validation All clinicians using the TOP should know the following 5 key messages

57 How is TOP useful clinically?
The TOP is a clinically useful tool for monitoring progress and identifying change during treatment TOP: Key facts Clinical usefulness Validation How is TOP useful clinically? A means of identifying and understanding change for an individual client (comparing TOP scores) Allows the keyworker to feedback the progress a client has made. The client can see these changes visually (using TOP Progress Tracker). Visual feedback may be more effective than verbal feedback alone Assistance given in the care planning process; highlighting areas of difficulty that may need addressing to increase the potential treatment gains Helps summarise the clients current situation and stimulates discussions in clinical meetings and supervision Provides the keyworker with an additional source of information/evidence that could be used when discussing a specific care plan

58 How to complete the Treatment Outcomes Profile (TOP)
TOP: Key facts Clinical usefulness Validation Client identifiers required to prevent double counting in the NDTMS Record the number of days in which the client has used each drug. A number should always be used (0-28) except when a client declines to answer which should be recorded as ‘NA’ Record the number of days that the client has injected. If the client does not inject record ‘0’. Do NOT use ‘NA’. Also record whether the client has shared by marking the box with a ‘Y’ or ‘N’ Some clients commit crime in order to fund their drug use. An obvious treatment goal is to reduce this activity. Record the number of days (0-28) for section 3a & b and ‘Y’ or ‘N’ if the client has committed crimes (c,d,e,f) in the last 28 days Circle the rating scales for Psychological, Physical & Quality of Life in accordance to where the client indicates. Record the number of days paid work and college between (0-28) and only use ‘NA’ if the client declines to answer

59 Three types of questions
Yes and no a simple tick for yes or no Timeline the client recalls the number of days in each of the past four weeks on which they did something, e.g. the number of days they used heroin Rating scale a 20-point scale from poor to good. Together with the client, mark the scale in an appropriate place 59

60 Completion and non-responses
Ask every question, complete every blue box Enter "NA" in the blue box: if client refuses to answer a question or if, even after prompting, client cannot recall 60

61 TOP NDTMS Data You should aim to ask and complete every question.
Do not leave any of the blue boxes blank Enter “NA” if a client refuses to answer a question or cannot recall. Where DAAT areas have incorporated the form into their own paperwork, the questions should be replicated exactly as they appear on the TOP form and need to be input into the NDTMS at the appropriate points in the client treatment. The above points apply to locally adapted paperwork as well. 61

62 When should the TOP be completed?
At start of new treatment journey to capture pre-treatment snapshot of client behaviour and situation And then every three months usually as part of a care plan review - to compare with pre-treatment snapshot and previous quarterly TOP results (Also on existing clients every three months) At Treatment Exit 62

63 Further Information & clinical tools
This is a very brief introduction to the TOP: more information is available at TOP: Key facts Clinical usefulness Validation This section is a very brief introduction to the TOP and covers only the very basic information that is required to start using the TOP with clients Further Information & clinical tools Guidance TOP reporting protocol: A keyworkers guide TOP completing TOP as a clinical interview TOP Progress Tracker guide (DET) TOP Service user guide NDTMS practice guide TOP Managers guide Clinical Tools TOP form TOP form (low ink version) TOP Progress tracker Calendar TOP training pack All the above information is available at or complete the online order form at Alternatively, or telephone and quote product code

64 Discharge Data and TOP Complete TOP at discharge from treatment system
This should be done face-to-face between keyworker and client where possible May be done over telephone where no other option available (i.e. in unplanned discharges) NOT acceptable to complete on clients’ behalf without client present 64

65 When should the TOP be completed?
Post discharge if feasible or desirable for service won’t be performance managed by NTA 65

66 TOP and Confidentiality
TOP data submitted via NDTMS will have the same safeguards in relation to confidentiality as any other NDTMS data This should be carefully explained to the client and local confidentiality agreements should be modified as appropriate to take into account the introduction of TOP into clinical and reporting systems 66

67 The benefits of the TOP continue to be recognised in clinical settings with its application in the UK and abroad having increased TOP: Key facts Clinical usefulness Validation Over the last 12 months the NTA has received several requests from European and International colleagues to use the TOP to measure outcomes in their clinics and countries. Requests received from It’s recognised that the TOP benefits from being Wales Scotland Northern Ireland Italy Taiwan Iran Australia Chile Russia Finland Canada Malta Spain New Zealand validated tool short & easy to complete Why? clinically useful tool captures a wide range of substances broadly covers all other relevant treatment domains

68 See the NTA website www. nta. nhs. org
See the NTA website for more information on the use of TOP internationally TOP: Key facts Clinical usefulness Validation

69 TOP Exceptions Let’s review the January TOP Exceptions that were released on DAMS on 5th March 2010. What action needs to be taken forward? Please refer to January TOP Exceptions that were published on DAMS on 05/03/2010. April 6, 2017

70 ANY QUESTIONS 70

71 Performance Management

72 GO THROUGH QUARTERLY PERFORMANCE REPORTS – provide each delegate with their agencies quarterly report.

73 DAT/AGENCY Quarterly Reports

74 Data Quality & Data Completeness

75 Objectives Focus on Data Quality Data Completeness
NDTMS Year End Review ( ) Regional Data Quality Initiatives How to address monthly data quality reports

76 Improving Service Provision
“Drug treatment services are managed using close to “real-time” data provided from the NDTMS and client satisfaction and client outcome data” (Models of Care: Update 2005, Consultation)

77 DTMU Data Quality Strategy
As part of SLA with NTA‚ an annual data quality strategy has to be produced and signed off by regional and central NTA. Covers the entire NDTMS dataset. Sets the data quality targets‚ which are based upon NTA HQ Monthly DQ Metrics. April 6, 2017

78 NTA Data Completeness Drivers
NTA National Requirements Percentage completion rate for Parental Status Percentage completion rate for Children Living With Hidden Harm PSA 14 – To prevent substance misuse amongst young people helping to reduce links with crime, disorder, truancy, school failure, physical and mental health problems. Hep B Vaccination Status responses versus Hep B Intervention status responses Route of Administration Inject versus Injecting Status Health Interventions/BBV PSA 18 – To promote better health and wellbeing of all citizens of society. Completion of Modality Start PSA 25 – to deliver a sustained 1% per annum increase (of people held in effective treatment) on baseline during Completion of Accommodation Need & Employment Status PSA 16 – to increase the proportion of socially of socially excluded adults in settled accommodation, employment education and trainings. 78

79 DTMU Data Completeness Analysis
DTMU release quarterly data completeness reports by partnership and by agency. Analysis is based on new presentations only. Quarterly /10 to be released in March. 79

80 Q2 Data Completeness Analysis
Let’s review the Q2 completeness that was released in early February. What action needs to be taken forward? 80

81 What data quality issues are you facing?
April 6, 2017

82 How can you improve your agency’s overall data quality and data completeness?

83 DTMU Answers Before submitting the monthly data submission check to see if all errors/warnings that could have occurred‚ have been addressed; Where amendments to client details have been made on your database‚ it is very important to notify Sue Dales to ensure that these changes are replicated on the regional NDTMS database. Ensure that all the fields that can be completed‚ are completed. April 6, 2017

84 DTMU Data Quality Standards
All monthly agency submissions must contain at least 100% valid records. All monthly agency submissions must reach 99.5% data quality All fields of CDS-F populated, if appropriate. Files must be in a CSV format. All agencies must submit via the Upload Portal: https://www.ndtms.org/dams/

85 ANY QUESTIONS Regina.Lally@SPH.nhs.uk Sue.Dales@SPH.nhs.uk

86 Dami. Omole@sph. nhs. uk. Michael. Wallington@sph. nhs. uk Regina


Download ppt "Drug Treatment Monitoring Unit"

Similar presentations


Ads by Google